We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer.AuthorsMcNeel, Douglas; Smith, Heath; Eickhoff, Jens; Lang, Joshua; Staab, Mary; Wilding, George; Liu, GlennPublicationCancer Immunology, Immunotherapy, 2012, Vol 61, Issue 7, p1137ISSN0340-7004Publication typearticleDOI10.1007/s00262-011-1193-1